C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01)
Patent
CA 2037211
The synthesis of 2,3-dihydro-1H-pyrrolo[1,2-a] benzimidazole-5,8-diones (azamitosenes) was carried out in conjunction with the design of potential DNA crosslinkers activated by reduction (reductive alkylation). These quinones resemble mitosene antitumor agents, but are based on the benzimidazole nucleus rather than the indole nucleus. Preliminary results indicate the azamitosenes are potent antitumor agents. Iminoquinone derivatives of azamitosenes (iminoazamitosenes) were synthesized as reductive alkylating agents exhibiting low oxygen toxicity. The iminoazamitosenes are hydrolytically stable in neutral buffers and undergo buffer catalyzed syn/anti isomerization at the imino center. Electrochemical and oxygen reactivity studies in aqueous buffers indicate the change from quinone to iminoquinone is accompanied by an increase in reduction potential and a decrease in oxygen reactivity of the corresponding reduced species.
Islam Imadul
Skibo Edward B.
Arizona Board Of Regents
Borden Ladner Gervais Llp
Research Corporation Technologies Inc.
LandOfFree
Synthesis and elucidation of azamitosene and iminoazamitosene does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Synthesis and elucidation of azamitosene and iminoazamitosene, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synthesis and elucidation of azamitosene and iminoazamitosene will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1539884